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1. Introduction
Acute pancreatitis(AP) in spite of thousands of experimental and clinical studies remains a
disease with significant impact in many countries being one of the most common gastrointes‐
tinal diseases requiring hospital admission in the United States[1]. Although the overall
mortality in AP patients is about 5% in severe AP is increasing up to 25 [2] mainly in elderly
people [3]
The aging process is believed to influence the course and outcome of AP. Indeed, AP in elderly
patients is associated with high morbidity and mortality [4]. Although Frey at al [5] have
related the presence of comorbidities in elderly patients to their increased mortality, others
consider advanced age to be an independent prognostic factor in AP [6].
The mechanisms underlying the increased severity of AP in elderly patients are not completely
understood. Possibilities include the presence of a proinflammatory status in older people [7]
or organ-specific alterations that may contribute to increased systemic inflammation in AP.
The lungs are particularly affected in AP, releasing a second wave of inflammatory mediators
that may increase systemic inflammation in older patients [8].
2. Aging and systemic inflammation
Cytokine production in elderly patients with sepsis is higher than in young people [9]. We
have observed that old people sometimes have a smooth initial postoperative course, followed
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by an increased inflammatory response that may have catastrophic outcomes. Delayed
explosive levels of interleukin (IL)-6 have been observed in elderly patients after surgery [10].
A recent report also demonstrated that the production of tumor necrosis factor (TNF)-α,
IL-1β or IL-6 in the lung cells of older subjects after exposure to lipopolysaccharide occurs
relatively late, but remain sustained when compared to lung cells from young subjects [11].
Monocyte activation and hypercytokinemia have also been observed in elderly patients after
surgical procedures [12] and in vitro studies have demonstrated that mitogen-stimulated
peripheral mononuclear cells from the elderly produce higher levels of TNF-α, IL-6, and IL-1
when compared to young subjects [13]. All these findings support the concept that aging affects
the immune system and promotes inflammation that is also associated with metabolic
dysfunctions [14].
3. Molecular mechanisms of the proinflammatory status related to aging
The molecular mechanisms involved in the proinflammatory condition of aged people are still
poorly understood, but inflammatory genes dysregulation may be involved in the process.
The potential role of the poly(ADPribose) polymerase-1 gene in inflammation and in the aging
process has been reported [15].
Higher splenic expression of toll-like receptor-4 and CD14 were also demonstrated in older
animals with sepsis when compared with young animals [16]. In this report, an increased 2A
adrenergic receptor and phosphodiesterase in older animals was also found. It was concluded
that in old animals the proinflammatory status is related to the innate immune response and
to the upregulation of the adrenergic autonomic nervous system that also may contribute to
the increased proinflammatory cytokine production [16].
Besides the proinflammatory condition in aging animals with acute pancreatitis, an increase
in plasma concentration of plasminogen activator inhibitor-1, a primary inhibitor of the
fibrinolytic system, has been shown in experimental pancreatitis resulting in increased extra
pancreatic thrombosis [17].
We are currently evaluating the differential gene expression in older patients with sepsis
compared to young patients. Recently, the important role of adipose triglyceride lipase (ATGL)
activity in the increased inflammatory status related to the aging process has been reported
[18]. Reduction of ATGL in aging animals is related to the increased inflammatory status in
these animals [18]. However, the mechanism by which ATGL modulates the production of
inflammatory mediators is still unknown.
4. Acute pancreatitis in the elderly population
The mortality rate in elderly patients is significantly higher than in younger patients(21.3
% vs 5.9%) [6].Recent clinical study also reported that elderly patients with severe acute
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pancreatitis have significant higher mortality rates than younger patients (17.0% vs 5.3%)
[20].We have observed similar findings in our own experience. Although no differences in
local  complications  in  acute  pancreatitis  between  young  and  elderly  people  have  been
observed,  the increased mortality  that  occurs with aging is  related to increased rates  of
organ failure [19–21].
The mechanisms underlying this increased distant organ failure and mortality associated with
aging is not completely understood. However, possible explanations include the increased
inflammatory response, worsened organ response to injury, or increased bacterial transloca‐
tion with increased systemic injury.
Recently, it was reported that there is a loss of pancreatitis-associated proteins with aging.
These are a group of innate pancreatic proteins with a protective effect, that are induced in the
process of AP and that are related to the increased severity of acute pancreatitis in the aging
population [22].
However in elderly patients with AP, there is a similar occurrence of local complications
associated with a significant increase in multiple organ failure when compared to young
patients [20].
It is well established that older patients are more susceptible to infections in surgical proce‐
dures, probably related to an exaggerated inflammatory response after surgery that can be
attributed to the proinflammatory status of older people [23].
It is conceivable that in surgical procedures and in acute pancreatitis, bacterial translocations
due to increased intestinal damage may be the underlying process that increases distant organ
failure. Intestinal fatty acid binding protein (IFABP) is a 15-kd protein located at the tips of
intestinal mucosal villi usually undetected in plasma circulation. Recently it has been shown
that IFABP is a specific marker of gut epithelial dysfunction in clinical cases of acute pancrea‐
titis and a useful marker of the severity of the disease [24]. In our laboratory we also demon‐
strated in an experimental model of acute pancreatitis that plasma levels of IFABP are
correlated with bacterial translocation (unpublished data).
In fact we have demonstrated increased intestinal damage, evaluated by plasma levels of
ileal  fatty  acid  binding protein  in  an experimental  model  of  acute  pancreatitis  in  aging
animals  when  compared  to  young  animals.  This  increased  intestinal  damage  was  fol‐
lowed by increased bacterial translocation and pancreatic infection in old animals (unpub‐
lished data; Figs 1, 2 and 3).
This increased bacterial translocation in older animals when compared to young ones was
associated with an increased systemic damage characterized by increased pulmonary myelo‐
peroxidase, and increased serum levels of liver enzymes, creatinine and glucose.
We also demonstrated that expression of intestinal proinflammatory cytokines genes is
increased in aging animals with acute experimental pancreatitis. This increased intestinal
inflammatory process may be related to the intestinal damage observed in the elderly animals.
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Figure 1. Plasma ileal fat acid binding protein levels.
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Figure 2. Pancreatic infection.
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Figure 3. Correlation between plasma fat acid binding protein levels and bacterial translocation.
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This concept is supported by the observation that administration of anti-platelet-activating
factor reduces the bacterial translocation in a model of acute pancreatitis [25]. It is therefore
possible that the reduction in the increased intestinal inflammatory process may decrease
bacterial translocation and the systemic damage observed in aged patients.
Finally, we have been studying the role of antimicrobial peptides in aging. Surprisingly, we
found that the production of alpha-defensin-5 is increased in the ileum of old rats when
compared to young rats in an experimental model of acute pancreatitis (manuscript in
preparation). This finding goes against the prevalent hypothesis that the elderly are immuno‐
suppressed compared to the young. Antimicrobial peptides are ancient weapons of innate
immunity. Despite their killing properties, a wide variety of cellular responses is affected by
these molecules. Antimicrobial peptides are largely distributed in nature, being found in
protozoa, prokaryotes, invertebrates, vertebrates and plants. Further research is necessary to
understand the molecular pathways triggered by antimicrobial peptides during AP– whether
they are produced to attack bacteria that invade the bloodstream, as a result of bacterial
translocation, or are merely coordinating the innate immune response during sterile systemic
inflammation.
5. Special treatment strategy
Our current knowledge indicates that we need new strategies to reduce the exaggerated
inflammatory response in elderly patients with AP.
Previous reports from our group have shown that in experimental AP, peritoneal lavage [26],
administration of hypertonic saline solution [27], use of platelet-activating factor antagonists
[25], and administration of pentoxifylline [28] reduce the inflammatory response in acute
pancreatitis in young animals. We are now investigating if these strategies are also effective
in old animals.
Since bacterial translocation is increased in acute pancreatitis in aging animals with increased
distant organ damage it is conceivable that different therapeutic strategies should be used in
aged patients with acute pancreatitis. More liberal utilization of hemofiltration or even
peritoneal lavage [26,29] may decrease the plasma level of cytokines and therefore minimize
the systemic damage induced by these substances.
We agree with recent guidelines [30] that do not recommend the use of prophylactic antibiotics
in patients with severe acute pancreatitis. However, in elderly patients antibiotics may not be
prophylactic.
Recent experimental studies including ours (Fig 1) have demonstrated an increased bacterial
infiltration in pancreatic tissues in acute pancreatitis in old animals [22].
Early antibiotic treatment in these patients may reduce the effect of increased bacterial
translocation and the systemic inflammatory response may therefore decrease the age-related
mortality in acute pancreatitis.
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